NM_000325.6:c.431G>A
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM1PM2PM5PP3_StrongPP5
The NM_000325.6(PITX2):c.431G>A(p.Arg144Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R144G) has been classified as Uncertain significance.
Frequency
Consequence
NM_000325.6 missense
Scores
Clinical Significance
Conservation
Publications
- anterior segment dysgenesis 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- Axenfeld-Rieger syndrome type 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- ring dermoid of corneaInheritance: Unknown, AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
- aniridiaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- Axenfeld anomalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Axenfeld-Rieger syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial atrial fibrillationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Rieger anomalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Peters anomalyInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PITX2 | NM_000325.6 | c.431G>A | p.Arg144Gln | missense_variant | Exon 3 of 3 | ENST00000644743.1 | NP_000316.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Axenfeld-Rieger syndrome type 1 Pathogenic:1
- -
Anterior segment dysgenesis 4;C3714873:Axenfeld-Rieger syndrome type 1 Uncertain:1
This sequence change replaces arginine with glutamine at codon 91 of the PITX2 protein (p.Arg91Gln). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and glutamine. This variant is not present in population databases (ExAC no frequency). This missense change has been observed in individual(s) with PITX2-related conditions and/or Rieger syndrome (PMID: 28611552; Invitae). ClinVar contains an entry for this variant (Variation ID: 197883). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects PITX2 function (PMID: 24604414). This variant disrupts the p.Arg91 amino acid residue in PITX2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 29506241; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at